Front Month ICE Brent Crude Rose 4.02% This Week to Settle at $74.49 — Data Talk
Front Month ICE Brent Crude for Nov. delivery gained $2.88 per barrel, or 4.02% to $74.49 this week
--Largest one week gain since the week ending June 14, 2024
--Largest one week percentage gain since the week ending April 5, 2024
--Up for two consecutive weeks
--Up $3.43 or 4.83% over the last two weeks
--Largest two week gain since the week ending June 28, 2024
--Largest two week percentage gain since the week ending June 21, 2024
--Today it is down 39.00 cents or 0.52%
--Largest one day dollar and percentage decline since Tuesday, Sept. 10, 2024
--Down two of the past three sessions
--Off 22.85% from its 52-week high of $96.55 hit Wednesday, Sept. 27, 2023
--Up 7.66% from its 52-week low of $69.19 hit Tuesday, Sept. 10, 2024
--Down 20.14% from 52 weeks ago
--Off 18.30% from its 2024 settlement high of $91.17 hit Friday, April 5, 2024
--Up 7.66% from its 2024 settlement low of $69.19 hit Tuesday, Sept. 10, 2024
--Off 49.01% from its record high of $146.08 hit Thursday, July 3, 2008
--Month-to-date it is down 5.47%
--Year-to-date it is down $2.55 or 3.31%
All prices are calculated based on the settlement price of the current front month contract.
Source: Dow Jones Market Data
(END) Dow Jones Newswires
September 20, 2024 15:18 ET (19:18 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
Undervalued by 25% and Yielding 5%, This Stock Is a Buy
-
Can AI Predict Future Stock Returns?
-
The Best Energy Stocks to Buy Now
-
10 Undervalued Wide-Moat Stocks
-
Obesity Drugs: Can New Firms Take Market Share From Eli Lilly and Novo Nordisk?
-
New 4-Star Stocks
-
Intel Fair Value Left Unchanged Despite Qualcomm Takeover Talk